Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...

The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United ...

The finest minds from the pharma firmament will also be sharing insights on the changing landscape and on the new imperatives ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

We have already seen the first wave of AI-powered dangers. Deepfakes, bot accounts, and algorithmic manipulation on social ...

Sarah O’Keeffe recounts her fulfilling career path with Eli Lilly from employee to Senior Vice President, Product Research ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are ...